Advertisement

ADRENAL BMLS dec 2009.ppt

Apr. 2, 2023
Advertisement

More Related Content

Advertisement

ADRENAL BMLS dec 2009.ppt

  1. ENDOCRINE DISORDERS OF THE ADRENAL GLAND BMLS DEC 2009 1
  2. The Adrenal Gland: Introduction • The adrenal glands produce three major classes of hormones • The hormones aid in dealing with the multitude of small and large stresses • At least two of these groups - glucocorticoids and mineralocorticoids - are necessary for life 2
  3. Functional Anatomy of the Adrenal Gland • The two adrenal glands are located immediately anterior to the kidneys • Encased in a connective tissue capsule • Usually partially buried in an island of fat. • Adrenal glands are retroperitoneal. An inner medulla • , A source of the catecholamines epinephrine and norepinephrine (The chromaffin cell is the principle cell type) • Medulla is richly innervated by preganglionic sympathetic fibers (In essence, an extension of the sympathetic nervous system. An outer cortex, • Secretes several classes of steroid hormones (glucocorticoids and mineralocorticoids, plus a few others). • Histologic examination of the cortex reveals three concentric zones of cells that differ in the major steroid hormones they 3
  4. Adrenal Medullary Hormones • Adrenal medulla synthesize and secrete epinephrine and norepinephrine. • In humans roughly 80% of the catecholamine output is epinephrine • Following release into blood, these hormones bind adrenergic receptors on target cells • They induce essentially the same effects as direct sympathetic nervous stimulation 4
  5. Synthesis and Secretion of Catecholamines In Chromaffin cells 5
  6. • Norepinephine and epinephrine are stored in electron-dense granules (which also contain ATP and several neuropeptides) • Secretion of these hormones is stimulated by acetylcholine release from preganglionic sympathetic fibers innervating the medulla. • Many types of "stresses" stimulate secretion, including exercise, hypoglycemia and trauma • Catecholamines bind loosely to and are carried in the circulation by albumin and perhaps other serum proteins 6
  7. Adrenergic Receptors and Mechanism of Action • The physiologic effects of epinephrine and norepinephrine are initiated by their binding to adrenergic receptors on the surface of target cells. • Complex physiologic responses result from adrenal medullary stimulation because there are multiple receptor types which are differentially expressed in different tissues and cells. • The alpha and beta adrenergic receptors are defined by differential binding of various agonists and antagnonists and, more recently, by analysis of molecular clones 7
  8. • In general, catecholamines have the same effects on target organs as direct stimulation by sympathetic nerves • However their effect is longer lasting. • Additionally, of course, circulating hormones can cause effects in cells and tissues that are not directly innervated. • The physiologic consequences are responses which aid in dealing with stress. • Common stimuli include exercise, hypoglycemia, hemorrhage and emotional distress Physiologic Effects of Medullary Hormones 8
  9. Major effects mediated by Catecholamines • Increased rate and force of contraction of the heart muscle: this is predominantly an effect of epinephrine acting through beta receptors. • Constriction of blood vessels: norepinephrine, in particular, causes widespread vasoconstriction, resulting in increased resistance and hence arterial blood pressure. • Dilation of bronchioles: assists in pulmonary ventilation. • Stimulation of lipolysis in fat cells: this provides fatty acids for energy production in many tissues and aids in conservation of dwindling reserves of blood glucose. • Increased metabolic rate: oxygen consumption and heat production increase throughout the body in response to epinephrine. Medullary hormones also promote breakdown of glycogen in skeletal muscle to provide glucose for energy production. • Dilation of the pupils: particularly important in conditions of low ambient light. • Inhibition of certain "non-essential" processes: an example is inhibition of gastrointestinal secretion and motor activity 9
  10. Adrenal Steroids • In total, at least two to three dozen different steroids are synthesized • Two classes are of particular importance: Class of Steroid Major Representative Physiologic Effects Mineralocorticoids Aldosterone Na+, K+ and water homeostasis Glucocorticoids Cortisol Glucose homeostasis and many others 10
  11. • Additionally, the adrenal cortex produces some sex steroids (e.g. androgens -related congenital adrenal hyperplasia) • Some enzymes reside in endoplasmic reticulum and others inside mitochondria. • Hence, synthesis involves shuttling of the steroids between these two organelles. • Synthesis of the different steroids is not uniformly distributed through the cortex. • For example, the outermost group of cells (zona glomerulosa) synthesizes aldosterone, but essentially no cortisol or androgens (cells do not express the enzyme 17-alpha-hydroxylase which is necessary for synthesis of 17-hydroxypregnenolone and 17-hydroxyprogesterone). • 17-alpha-hydroxylase is present in cells of the inner zones of the cortex (zonae fasiculata and reticularis), which are the major sites of cortisol production 11
  12. Major Pathways in Steroid Biosynthesis 12
  13. Mineralocorticoids • The principal steroid with mineralocorticoid activity is aldosterone. • Cortisol, is said to have "weak mineralocorticoid activity" • Mineralocorticoids play a critical role in regulating concentrations of minerals - particularly sodium and potassium - in extracellular fluids 13
  14. Physiologic Effects of Mineralocorticoids • The major target of aldosterone is the distal tubule of the kidney, where it stimulates exchange of sodium and potassium. • Three primary physiologic effects of aldosterone result: - Increased resorption of sodium: sodium loss in urine is decreased under aldosterone stimulation. - Increased resorption of water, with consequent expansion of extracellular fluid volume. This is an osmotic effect directly related to increased resorption of sodium. • Increased renal excretion of potassium. 14
  15. Control of Aldosterone Secretion • Control over aldosterone secretion is multifactorial. • The two most significant regulators of aldosterone secretion are: - Concentration of potassium ions in extracellular fluid: Small increases in blood levels of potassium strongly stimulate aldosterone secretion. - Angiotensin II: Activation of the renin-angiotensin system as a result of decreased renal blood flow (usually due to decreased vascular volume) results in release of angiotensin II, which stimulates aldosterone secretion. • Other factors which stimulate aldosterone secretion include - adrenocorticotropic hormone (short-term stimulation only) - sodium deficiency. • Factors which suppress aldosterone secretion include - atrial naturetic hormone - high sodium concentration - potassium deficiency. 15
  16. Disease States • A deficiency in aldosterone can occur by itself • More commonly, in conjunction with a glucocorticoid deficiency (known as Addison's disease). • Without treatment by mineralocorticoid replacement therapy, a lack of aldosterone is lethal - due to: - electrolyte imbalances - hypotension and cardiac failure 16
  17. Addison’s disease Adrenocortical insufficiency usually as the result of idiopathic atrophy or destruction of both adrenal glands by tuberculosis, an autoimmune process, or other diseases; characterized by decreased serum electrolytes and cortisol , fatigue, decreased blood pressure, weight loss, increased melanin pigmentation of the skin and mucous membranes, anorexia, and nausea or vomiting; without appropriate replacement therapy, it can progress to acute adrenocortical insufficiency. 17
  18. Glucocorticoids (cortisol ) • Failure to produce glucocorticoids is not acutely life-threatening. • Loss or profound diminishment of glucocorticoid secretion leads to a state of - deranged metabolism - inability to deal with stressors - if untreated, is fatal. • In addition glucocorticoids frequently used drugs - prescribed for their anti-inflammatory and - immunosuppressive properties. 18
  19. Physiologic Effects of Glucocorticoids • No cells that lack glucocorticoid receptors • These steroid hormones have a huge number of effects on physiologic systems. • Best known and studied effects of glucocorticoids are on carbohydrate metabolism and immune function 19
  20. Effects on Metabolism • Glucose metabolism (hence the name glucocorticoid). • In the fasted state, cortisol stimulates several processes that collectively serve to increase and maintain normal concentrations of glucose in blood. These effects include: • Stimulation of gluconeogenesis, particularly in the liver: This pathway results in the synthesis of glucose from non-hexose substrates such as amino acids and lipids • Mobilization of amino acids from extrahepatic tissues: These serve as substrates for gluconeogenesis. • Inhibition of glucose uptake in muscle and adipose tissue: A mechanism to conserve glucose. • Stimulation of fat breakdown in adipose tissue: The fatty acids released by lipolysis are used for production of energy in tissues like muscle, and the released glycerol provide another substrate for gluconeogenesis. 20
  21. Effects on Inflammation and Immune Function • Glucocorticoids have potent anti- inflammatory and immunosuppressive properties. • This is particularly evident when they administered at pharmacologic doses • Glucocorticoids are widely used as drugs to treat inflammatory conditions such as arthritis or dermatitis • Glucocorticoids are used as adjunction therapy for conditions such as autoimmune diseases. 21
  22. Other Effects of Glucocorticoids • Glucocorticoids have multiple effects on fetal development. - role in promoting maturation of the lung and production of the surfactant necessary for extrauterine lung function. . • Several aspects of cognitive function are known to both stimulate glucocorticoid secretion and be influenced by glucocorticoids. • Excessive glucocorticoid levels may cause: - inhibition of bone formation - suppression of calcium absorption - and delayed wound healing. • These observations suggest a multitide of less dramatic physiologic roles for glucocorticoids 22
  23. Cortisol Disease States • Hyperadrenocorticism or Cushings disease. The most prevalent disorder involving glucocorticoids in man • Excessive levels of glucocorticoids are seen in two situations: - Excessive endogenous production of cortisol (can result from a primary adrenal defect (ACTH-independent) or from excessive secretion of ACTH (ACTH-dependent). - Administration of glucocorticoids for theraputic purposes ( common side-effect of these widely-used drugs). • Cushing's disease has widespread effects on - metabolism and - organ function, • Clinical manifestations accompany this disorder - Hypertension, obesity, muscle wasting, thin skin, metabolic aberrations such as diabetes 23
  24. Cushing's syndrome • Also called hyperadrenocorticism or hypercorticism) • A disorder caused by high levels of cortisol • Can be caused by: - Taking glucocorticoid drugs - Tumors that produce cortisol or ACTH • Cushing's disease refers to one specific cause, a non-cancerous tumor (adenoma) in the pituitary gland that produces large amounts of ACTH • It was described by American Dr. Harvey Cushing in 1932 24
  25. Exogenous vs. endogenous • The most common is exogenous administration of glucocorticoids • Endogenous Cushing's syndrome: - pituitary Cushing's, a benign pituitary adenoma secretes ACTH. - Also known as Cushing's disease - Responsible for 65% of endogenous Cushing's syndrome. • In adrenal Cushing's - excess cortisol is produced by adrenal gland tumors, hyperplastic adrenal glands, or adrenal glands with nodular adrenal hyperplasia. • Paraneoplastic Cushing's syndrome - Seen in diseases like small cell lung cancer. 25
  26. ACTH-dependent vs. ACTH-independent • Cushing's syndrome can also be sub-classified according to whether or not the excess cortisol is dependent on increased ACTH. • ACTH-dependent Cushing's syndrome - driven by increased ACTH (exogenous ACTH administration, pituitary and ectopic Cushing's). • ACTH-independent Cushing's syndrome - increased cortisol, - ACTH is decreased due to negative feedback. - Can be caused by exogenous administration of glucocorticoids or by adrenal adenoma, carcinoma, or nodular hyperplasia. 26
  27. Signs and symptoms • Symptoms include: - Rapid weight gain, particularly of the trunk and face with sparing of the limbs (central obesity). - Fat pads along the collar bone and on the back of the neck (buffalo hump) - Round face often referred to as a "moon face". • Other symptoms include - excess sweating, telangiectasia (dilation of capillaries) - thinning of the skin (which causes easy bruising and dryness, particularly the hands) and other mucous membranes, purple or red - hirsutism (facial male-pattern hair growth). - effects other endocrine systems and cause (insomnia, reduced libido, impotence, amenorrhoea and infertility. - Various psychological disturbances, ranging from euphoria to psychosis. Depression and anxiety 27
  28. • Other features - persistent hypertension (due to cortisol's enhancement of epinephrine's vasoconstrictive effect) - insulin resistance (especially common in ectopic ACTH production), leading to diabetes mellitus. - Cushing's syndrome due to excess ACTH may also result in hyperpigmentation (due to Melanocyte-Stimulating Hormone production as a byproduct of ACTH synthesis from Pro- opiomelanocortin (POMC). 28
  29. • Cortisol can also exhibit mineralcorticoid activity in high concentrations, worsening the hypertension and leading to hypokalemia (common in ectopic ACTH secretion). • Opportunistic infections and impaired wound healing (cortisol is a stress hormone, so it depresses the immune and inflammatory responses). • Osteoporosis is also an issue in Cushing's syndrome since, as mentioned before, cortisol evokes a stress-like response. • oligomenorrhea (decreased frequency of menstruation) due to elevations in androgens (male sex hormones), normally at low levels in women. 29
  30. Lab Diagnosis • Basal levels of Cortisol and ACTH • Dexamethasone suppression test - administration of dexamethasone and - frequent determination of cortisol and ACTH level), or a - 24-hour urinary measurement for cortisol • Dexamethasone is a glucocorticoid and simulates the effects of cortisol, including negative feedback on the pituitary gland. • When dexamethasone is administered and a blood sample is tested, high cortisol would be indicative of Cushing's syndrome because there is an ectopic source of cortisol or ACTH (eg: adrenal adenoma) that is not inhibited by the dexamethasone. • A novel approach, recently cleared by the US FDA, is sampling cortisol in saliva over 24 hours, which may be equally sensitive, as late night levels of salivary cortisol are high in Cushingoid patients 30
  31. Addison’s Disease • Primary adrenocortical insufficiency • Due to the destruction or dysfunction of the entire adrenal cortex. • It affects glucocorticoid and ineralocorticoid function. • The onset of disease usually occurs when 90% or more of both adrenal cortices are dysfunctional or destroyed. • Patients may present with - clinical features of chronic Addison disease or - in acute addisonian crisis (precipitated by stress factors such as infection, trauma, surgery) 31
  32. Presentation of chronic Addison disease • The onset of symptoms most often is insidious and nonspecific. • Hyperpigmentation • Progressive weakness, fatigue, poor appetite, and weight loss. • Nausea, vomiting, and occasional diarrhea. 32
  33. Presentation of acute Addison disease • Prominent nausea, vomiting, and vascular collapse. • Shock • cyanotic and confused. • Abdominal symptoms may take on features of an acute abdomen. • In acute adrenal hemorrhage, the patient, usually in an acute care setting, deteriorates with sudden collapse, abdominal or flank pain, and nausea with or without hyperpyrexia 33
  34. Causes • The most common cause of Addison disease is idiopathic autoimmune adrenocortical insufficiency • Resulting from autoimmune atrophy, fibrosis, and lymphocytic infiltration of the adrenal cortex - Usually with sparing of the adrenal medulla - This accounts for more than 80% of reported cases. - Idiopathic autoimmune adrenocortical atrophy and tuberculosis (TB) account for nearly 90% of cases of Addison disease. 34
  35. • Antibodies against the adrenal tissue are present in a significant number of these patients, • Evidence of cell-mediated immunity against the adrenal gland also may be present. • The steroidogenic enzyme 21-hydroxylase (21OH) is the main autoantigen • Patients may have a hereditary predisposition to autoimmune Addison disease. • Idiopathic autoimmune Addison disease may occur in isolation or in association with other autoimmune phenomena (eg, polyglandular autoimmune disease types 1 and 2). 35
  36. Additional causes of chronic Addison disease • Chronic granulomatous diseases (TB of the adrenal glands usually is a tertiary disease due to the hematogenous spread of infection) • Hematologic malignancies (Hodgkin and non-Hodgkin lymphoma and leukemia) • Metastatic malignant disease • Infiltrative metabolic disorders - Amyloidosis and hemochromatosis • Acquired immunodeficiency syndrome • Congenital adrenal hyperplasia • Drug-related causes • Abdominal irradiation 36
  37. Causes of acute Addison disease • Stress - • Failure to increase steroids • Bilateral adrenal hemorrhage • Bilateral adrenal artery emboli and bilateral vein thrombosis • Bilateral adrenalectomy for any reason 37
  38. Laboratory Diagnosis • Rests on the assessment of the functional capacity of the adrenal cortex to synthesize cortisol. • This is accomplished primarily by use of the rapid ACTH stimulation test (Cortrosyn, cosyntropin, or Synacthen) – ACTH, through complex mechanisms, activates cholesterol esterase enzymes and leads to the release of free cholesterol from cholesterol esters. It also activates the 20,22-desmolase enzyme, which catalyzes the rate- limiting step in adrenal steroidogenesis and increases the NADPH (nicotinamide adenine dinucleotide phosphate) levels necessary for the various hydroxylation steps in steroidogenesis. • Within 15-30 minutes of ACTH infusion, the normal adrenal cortex releases 2-5 times its basal plasma cortisol output 38
  39.  In acute adrenal crisis, where treatment should not be delayed in order to do the tests, a blood sample for a random plasma cortisol level should be drawn prior to starting hydrocortisone replacement. 39
  40. Other laboratory tests • Comprehensive metabolic panel • The most prominent findings are - hyponatremia, hyperkalemia, and a mild non– anion-gap metabolic acidosis due to the loss of the sodium-retaining and potassium and hydrogen ion-secreting action of aldosterone. • The most consistent finding is elevated blood urea nitrogen (BUN) and creatinine due to the hypovolemia, a decreased glomerular filtration rate, and a decreased renal plasma flow.  Adrenal autoantibodies may be present. 40
  41. Pheochromocytoma • A rare catecholamine-secreting tumor derived from chromaffin cells. • Tumors that arise outside the adrenal gland are termed extra-adrenal pheochromocytomas or paragangliomas. • Because of excessive catecholamine secretion, pheochromocytomas may precipitate life- threatening hypertension or cardiac arrhythmias. • If the diagnosis of a pheochromocytoma is overlooked, the consequences could be disastrous, even fatal • If a pheochromocytoma is found, it is potentially curable. 41
  42. The clinical Manifestations • Result from excessive catecholamine secretion by the tumor. • Stimulation of alpha-adrenergic receptors results in elevated blood pressure, increased cardiac contractility, glycogenolysis, gluconeogenesis, and intestinal relaxation. • Stimulation of beta-adrenergic receptors results in an increase in heart rate and contractility. 42
  43. • Catecholamine secretion in pheochromocytomas is not regulated in the same manner as in healthy adrenal tissue. • Unlike the healthy adrenal medulla, pheochromocytomas are not innervated, and catecholamine release is not precipitated by neural stimulation. • The trigger for catecholamine release is unclear, but multiple mechanisms have been postulated, including direct pressure, medications, and changes in tumor blood flow. • Relative catecholamine levels also differ in pheochromocytomas. - Normal adrenal medulla is composed of roughly 85% epinephrine - Most pheochromocytomas contain norepinephrine predominantly (except in Familial pheochromocytomas) 43
  44. Clinics (Cardiovascular morbidity) • Cardiovascular morbidity: - Hypertension is the most common complication - Cardiac arrhythmias, such as atrial and ventricular fibrillation, may occur - Myocarditis - signs and symptoms of myocardial infarction - dilated cardiomyopathy - pulmonary edema, either of cardiac or noncardiac origin. 44
  45. Laboratory Studies  Plasma metanephrine testing has the highest sensitivity (96%) for detecting a pheochromocytoma, but it has a lower specificity (85%).  In comparison, a 24-hour urinary collection for catecholamines and metanephrines has a sensitivity of 87.5% and a specificity of 99.7%. • Chromogranin A levels are sometimes used to detect recurrent pheochromocytomas. • Plasma levels of chromogranin A reportedly are 83% sensitive and 96% specific for identifying a pheochromocytoma. 45
  46. • Chromogranin A is an acidic monomeric protein that is stored with and secreted with catecholamines 46
  47. Neurologic complications • A pheochromocytoma-induced hypertensive crisis may precipitate hypertensive encephalopathy • Focal neurologic signs and symptoms, or seizures. • Other neurologic complications include - stroke due to cerebral infarction or an embolic event secondary to a mural thrombus from a dilated cardiomyopathy. - Intracerebral hemorrhage also may occur because of uncontrolled hypertension 47
Advertisement